Surface-modified vacuole-based daunorubicin delivery system for acute myeloid leukaemia (AML) and their selective therapeutics

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

(2019) Mehdi Ghasemi et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Encapsulation of daunorubicin into Saccharomyces cerevisiae-derived lysosome as drug delivery vehicles for acute myeloid leukemia (AML) treatment

(2019) Wooil Choi et al.   JOURNAL OF BIOTECHNOLOGY

Cancer drug delivery in the nano era: An overview and perspectives

(2017) Zhen Li et al.   ONCOLOGY REPORTS

Affibody Molecules in Biotechnological and Medical Applications

(2017) Stefan Ståhl et al.   TRENDS IN BIOTECHNOLOGY

Enhanced lysosomal activity by overexpressed aminopeptidase Y in Saccharomyces cerevisiae

(2016) Jihee Yoon et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy

(2015) Justyna Rybka et al.   LEUKEMIA RESEARCH

Bioengineered yeast-derived vacuoles with enhanced tissue-penetrating ability for targeted cancer therapy

(2015) Vipul Gujrati et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death

(2014) Ana M. Villamil Giraldo et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1

(2014) Guo-Yun Chen et al.   eLife

Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide

(2013) Ke Li et al.   INTERNATIONAL JOURNAL OF CANCER

Yeast vacuoles: more than a model lysosome

(2010) John Armstrong   TRENDS IN CELL BIOLOGY

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY